Latest news with #MHRAYellowCard
Scottish Sun
07-07-2025
- Health
- Scottish Sun
Eye drops used as hayfever remedy urgently recalled over risk of severe infection
URGENT RECALL Eye drops used as hayfever remedy urgently recalled over risk of severe infection BRITS have been warned eyedrops used as a hayfever remedy have been recalled over risk of serious infection. Retailers have been advised to "stop supplying" the affected batch "immediately". Potential side effects include a number of eye infections, including conjunctivitis, keratitis, and/or blepharitis, or, for susceptible patients, could be a more severe infection. A spokesperson from Medicines and Healthcare products Regulatory Agency said: "Class 2 Medicines Recall: Zaditen 0.25 mg/ml, eye drops, solution, Laboratoires Théa EL(25)A/34. "Laboratoires Théa trading as Thea Pharmaceuticals Limited have notified the MHRA of an out of specification event related to environmental monitoring during manufacturing, which may increase the risk of microbial contamination of the medicinal product. "As a precautionary measure the specific batch mentioned in this notification is being recalled. "To date, Thea Pharmaceuticals Limited have not received any reports of adverse incidents or product quality complaints related to this potential defect." The affected batch are number 4V64, with the expiry date September 30, 2026. The pack size is 5ml, and they were first distributed on January 27 this year. All stock must also be quarantined, and returned to the supplier, using the approved process. Thea Pharmaceuticals confirmed 11,360 packs of this batch were released and distributed. There have been no reported adverse events or product quality complaints received to date. And, no further action is required by patients as this is a Pharmacy and Wholesaler level recall. The spokesperson added: "Whilst the recall is precautionary and no adverse events have been reported by Thea Pharmaceuticals Limited, if any side effects were to be observed, these would be related to ocular infection and may include conjunctivitis, keratitis, and/or blepharitis, or, for susceptible patients, could be a more severe infection. "Patients who experience adverse reactions or have any questions about the medication should seek medical attention. "Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme." Your product recall rights Chief consumer reporter James Flanders reveals all you need to know. Product recalls are an important means of protecting consumers from dangerous goods. As a general rule, if a recall involves a branded product, the manufacturer would usually have lead responsibility for the recall action. But it's often left up to supermarkets to notify customers when products could put them at risk. If you are concerned about the safety of a product you own, always check the manufacturer's website to see if a safety notice has been issued. When it comes to appliances, rather than just food items, the onus is usually on you - the customer - to register the appliance with the manufacturer as if you don't there is no way of contacting you to tell you about a fault. If you become aware that an item you own has been recalled or has any safety noticed issued against it, make sure you follow the instructions given to you by the manufacturer. They should usually provide you with more information and a contact number on its safety notice. In some cases, the manufacturer might ask you to return the item for a full refund or arrange for the faulty product to be collected. You should not be charged for any recall work - such as a repair, replacement or collection of the recalled item 1 The Zaditen 0.25 mg/ml, eye drops and solution have been recalled Credit: Getty More to follow... For the latest news on this story keep checking back at The Sun Online is your go-to destination for the best celebrity news, real-life stories, jaw-dropping pictures and must-see video. Like us on Facebook at and follow us from our main Twitter account at @TheSun.
The Irish Sun
07-07-2025
- Health
- The Irish Sun
Eye drops used as hayfever remedy urgently recalled over risk of severe infection
BRITS have been warned eyedrops used as a hayfever remedy have been recalled over risk of serious infection. Retailers have been advised to "stop supplying" the affected batch "immediately". Potential side effects include a number of eye infections, including conjunctivitis, keratitis, and/or blepharitis, or, for susceptible patients, could be a more severe infection. A spokesperson from Medicines and Healthcare products Regulatory Agency said: "Class 2 Medicines Recall: Zaditen 0.25 mg/ml, eye drops, solution, Laboratoires Théa EL(25)A/34. "Laboratoires Théa trading as Thea Pharmaceuticals Limited have notified the MHRA of an out of specification event related to environmental monitoring during manufacturing, which may increase the risk of microbial contamination of the medicinal product. "As a precautionary measure the specific batch mentioned in this notification is being recalled. Read More "To date, Thea Pharmaceuticals Limited have not received any reports of adverse incidents or product quality complaints related to this potential defect." The affected batch are number 4V64, with the expiry date September 30, 2026. The pack size is 5ml, and they were first distributed on January 27 this year. All stock must also be quarantined, and returned to the supplier, using the approved process. Most read in The Sun Thea Pharmaceuticals confirmed 11,360 packs of this batch were released and distributed. There have been no reported adverse events or product quality complaints received to date. And, no further action is required by patients as this is a Pharmacy and Wholesaler level recall. The spokesperson added: "Whilst the recall is precautionary and no adverse events have been reported by Thea Pharmaceuticals Limited, if any side effects were to be observed, these would be related to ocular infection and may include conjunctivitis, keratitis, and/or blepharitis, or, for susceptible patients, could be a more severe infection. "Patients who experience adverse reactions or have any questions about the medication should seek medical attention. "Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme." Your product recall rights Chief consumer reporter James Flanders reveals all you need to know. Product recalls are an important means of protecting consumers from dangerous goods. As a general rule, if a recall involves a branded product, the manufacturer would usually have lead responsibility for the recall action. But it's often left up to supermarkets to notify customers when products could put them at risk. If you are concerned about the safety of a product you own, always check the manufacturer's website to see if a safety notice has been issued. When it comes to appliances, rather than just food items, the onus is usually on you - the customer - to register the appliance with the manufacturer as if you don't there is no way of contacting you to tell you about a fault. If you become aware that an item you own has been recalled or has any safety noticed issued against it, make sure you follow the instructions given to you by the manufacturer. They should usually provide you with more information and a contact number on its safety notice. In some cases, the manufacturer might ask you to return the item for a full refund or arrange for the faulty product to be collected. You should not be charged for any recall work - such as a repair, replacement or collection of the recalled item 1 The Zaditen 0.25 mg/ml, eye drops and solution have been recalled Credit: Getty More to follow... For the latest news on this story keep checking back at The Sun Online is your go-to destination for the best celebrity news, real-life stories, jaw-dropping pictures and must-see video. Like us on Facebook at
Scottish Sun
11-06-2025
- Health
- Scottish Sun
Popular laxatives found to contain WRONG dose instruction – and children could be at risk
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) PARENTS are being alerted after popular laxatives were found to have a potentially dangerous labelling error. Boxes of Dulcolax, which should only be taken by adults, wrongly suggest they're suitable for kids aged 12 and over. Sign up for Scottish Sun newsletter Sign up 1 Dulcolax Adult 5mg gastro-resistant tablets have been hit by a labeling error. Credit: Dulcolax The Medicines and Healthcare products Regulatory Agency (MHRA), which issued the alert, said the printing blunder is not "expected" to cause harm. 'Based on the safety assessment, it was concluded that there is no harm expected to children who may have taken this medication,' the watchdog said. The tablets themselves are safe. But the instructions could lead to kids taking them without proper advice. Dulcolax Adult 5mg gastro-resistant tablets contain 5mg of bisacodyl - a common over-the-counter constipation treatment. There's a separate version called Dulcolax Twelve Plus for kids aged 12 and over. It has the same 5mg dose as the adult tablets. But it's only available from a pharmacist, who can give advice on the right way to use it for children. That's because their bodies handle medicine differently, and experts make sure it's safe and used right. It stops kids taking too much or using laxatives when they shouldn't. Dulcolax Adult 5mg gastro-resistant tablets are available over-the-counter, meaning any adult can buy them without a prescription or pharmacist advice. The batch codes to look out for are 240908, 240909, 241873, 241875, 250222, 250307, and 250308. You can find these numbers on the packaging. The 3-minute tummy massage to ease bloating, constipation and trapped wind The affected batches have an expiry date of the 30 and 31 of May 2027 and were distributed this year. "Adult patients should continue to take medicines from the impacted batches," the MHRA wrote, in the alert published yesterday (June 10). The quality of the product is not affected which is why the products are not being recalled and will remain to be available for sale. "There is an error on the back of the carton, this product is only intended for use by adults (18 years and over) and should not be used in children (under the age of 18)." Some boxes have already been distributed to pharmacies and shops, but future stock will only be sent to pharmacies and healthcare stores until the packaging is corrected. Adults are advised to keep taking the tablets as normal, following the leaflet inside the pack - which contains the correct instructions. People who experience adverse reactions or have any questions about their medication should seek medical attention. "Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme," the alert said.
